AIM
ModiHost Rank 2197
Website
Twitter
1,246,664 AIM
Buy / Sell
Get Wallet
ModiHost
ModiHost Price $0.01
$0.01
ModiHost 24h Vol
$0
$0
ModiHost Market Cap $11,258
$11,258
24h Vol
0 BTC 1 H
0.53 %
24 H
1.02 %
7 d
2.55 %
Today ModiHost price in US dollars is currently
0.0090
USD, and if converted to Bitcoin is
0.00000021
BTC. A total of 1,246,664 AIM are currently circulating in the Market. ModiHost price is currently experiencing a change of 1.02 %, and check here all cryptocurrency. Over the past 24 hours 0.000 M US dollars ModiHost have been traded on Crypto Exchanges. Get ModiHost's progress by adding it to your favourites and creating a free portfolio.
Full Name
ModiHost
Symbol
AIM
Algorithm
BTC Price
0.00000021 BTC
BTC Market
0 BTC
BTC 24h Vol
0 BTC
Total Coins Mined
1,246,664 AIM
1h
0.53 %
24h
1.02 %
7d
2.55 %
Twitter
Website
Share ModiHost Price
Description
Description
Aimedis is a medical care platform. It works as an intermediary between doctors and patients in order to create a medical data marketplace, where users can provide medical data to the doctors, and doctors can diagnose patients. At Aimedis, online medical prescriptions are possible as well as access to A.I. (Artificial Intelligence) tools that are able to examine medical data.
The Aimedis (AIM) token is an Ethereum-based (ERC-20) cryptocurrency. It will serve the users as a medium to exchange value between them and/or to pay for other users medical services when using Aimedis. In addition, to buy or sell medical data, AIM tokens are required.
| Full Name | Aimedis (AIM) |
|---|---|
| Start Date | N/A |
| Algorithm | N/A |
| Proof Type | N/A |
| Website | https://aim.aimedis.com |
| @AimedisGlobal | |
| N/A | |
| N/A | |
| Block Number | N/A |
| Block Time | N/A |
| Block Reward | N/A |
| Total Coins Mined | 1,246,664 AIM |
| Previous Total Coins Mined | N/A |
| Net Hashes Per Second | N/A |
ICO Details
ICO Details
Aimedis is a medical care platform. It works as an intermediary between doctors and patients in order to create a medical data marketplace, where users can provide medical data to the doctors, and doctors can diagnose patients. At Aimedis, online medical prescriptions are possible as well as access to A.I. (Artificial Intelligence) tools that are able to examine medical data.
The Aimedis (AIM) token is an Ethereum-based (ERC-20) cryptocurrency. It will serve the users as a medium to exchange value between them and/or to pay for other users medical services when using Aimedis. In addition, to buy or sell medical data, AIM tokens are required.
Team:
- Dr. Michael J. Kaldasch: CEO, MD & founder.
- Dr. Ben El Idrissi: COO, MD & founder.
- Sankar Ghanesh: CTO.
- Dr. Lazaros Fountoukidis: CMO & MD.
Aimedis ICO will begin on TBA. The ICO token supply represents 50% of the total token supply, so there is a total of 300,000,000 AIM tokens available, for 0.12 USD each. The ICO funding target is 9,000,000 USD, the funding cap is 36,000,000 USD and is expected to end on TBA or when the funding cap is reached.
Token Reserve Split (50%):
- 20% Community initiatives, marketing & legal;
- 20% Team, supporters & advisory board;
- 5% Legal reserve;
- 5% Reserve.
Aimedis ICO features a bonus of 20% upon the Pre-Sale.
| ICO Status | Upcoming |
|---|---|
| Token Supply | 600000000 |
| Start Date | N/A |
| End Date | N/A |
| Fund Raised (BTC) | N/A |
| Fund Raised (USD) | N/A |
| Start Price (USD) | 0.12 |
| Security Audit Company | N/A |
| ICO Legal Form | Corporation |
| ICO Jurisdiction | Netherlands |
| Legal Advisers | N/A |
| Blog | https://medium.com/@aimedisglobal |
| White Paper | https://aim.aimedis.com/pdf/WhitepaperEN10.pdf |
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.